Concurrent chemoradiotherapy improves survival in patients with hypopharyngeal cancer

P Paximadis, G Yoo, HS Lin, J Jacobs, A Sukari… - International Journal of …, 2012 - Elsevier
PURPOSE: To retrospectively review our institutional experience with hypopharyngeal
carcinoma with respect to treatment modality. METHODS AND MATERIALS: A total of 70 …
被引用次数：35 相关文章

Concurrent chemoradiotherapy improves survival in patients with hypopharyngeal cancer

P Paximadis, G Yoo, HS Lin… - … journal of radiation …, 2012 - pubmed.ncbi.nlm.nih.gov
Purpose To retrospectively review our institutional experience with hypopharyngeal
carcinoma with respect to treatment modality. Methods and materials A total of 70 patients …

Concurrent Chemoradiotherapy Improves Survival in Patients With Hypopharyngeal Cancer

P Paximadis, G Yoo, HS Lin, J Jacobs, A Sukari… - International Journal of …, 2012 - infona.pl
To retrospectively review our institutional experience with hypopharyngeal carcinoma with
respect to treatment modality. A total of 70 patients with hypopharyngeal cancer treated …

Concurrent Chemoradiotherapy Improves Survival in Patients With Hypopharyngeal Cancer

P Paximadis, G Yoo, HS Lin, J Jacobs… - International Journal of …, 2012 - redjournal.org
Purpose To retrospectively review our institutional experience with hypopharyngeal
carcinoma with respect to treatment modality. Methods and Materials A total of 70 patients …

Concurrent Chemoradiotherapy Improves Survival in Patients With Hypopharyngeal Cancer

P Paximadis, G Yoo, HS Lin, J Jacobs… - International Journal of …, 2012 - inis.iaea.org
[en] Purpose: To retrospectively review our institutional experience with hypopharyngeal
carcinoma with respect to treatment modality. Methods and Materials: A total of 70 patients …

Concurrent chemoradiotherapy improves survival in patients with hypopharyngeal cancer.

P Paximadis, G Yoo, HS Lin, J Jacobs… - … Journal of Radiation …, 2011 - europepmc.org
Results The median follow-up was 18 months. The median overall survival and disease-free
survival for all patients was 28.3 and 17.6 months, respectively. The 1-and 2-year local …
[HTML] nih.gov

[HTML][HTML] Concurrent Chemoradiotherapy Improves Survival in Patients With Hypopharyngeal Cancer

P Paximadis, G Yoo, HS Lin, J Jacobs… - … journal of radiation …, 2012 - ncbi.nlm.nih.gov
Results The median follow-up was 18 months. The median overall survival and disease-free
survival for all patients was 28.3 and 17.6 months, respectively. The 1-and 2-year local …

Concurrent Chemoradiotherapy Improves Survival in Patients With Hypopharyngeal Cancer

P Paximadis, G Yoo, HS Lin, J Jacobs, A Sukari… - International Journal of …, 2012 - osti.gov
Purpose: To retrospectively review our institutional experience with hypopharyngeal
carcinoma with respect to treatment modality. Methods and Materials: A total of 70 patients …

[引用][C] CONCURRENT CHEMORADIOTHERAPY IMPROVES SURVIVAL IN PATIENTS WITH HYPOPHARYNGEAL CANCER

P PAXIMADIS, G YOO, HS LIN… - … journal of radiation …, 2012 - pascal-francis.inist.fr
CONCURRENT CHEMORADIOTHERAPY IMPROVES SURVIVAL IN PATIENTS WITH
HYPOPHARYNGEAL CANCER CNRS Inist Pascal-Francis CNRS Pascal and Francis …

[引用][C] Concurrent Chemoradiotherapy Improves Survival in Patients With Hypopharyngeal Cancer

P Paximadis, G Yoo, HS Lin, J Jacobs… - International Journal of …, 2012 - cir.nii.ac.jp
Concurrent Chemoradiotherapy Improves Survival in Patients With Hypopharyngeal Cancer |
CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …